LFCR / Lifecore Biomedical stock climbs 19% on $150 million refinancing deal

Lifecore Biomedical (LFCR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get pre more_horizontal

Lifecore Biomedical (LFCR) came out with a quarterly loss of $0.89 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to more_horizontal

CHASKA, Minn., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract developm more_horizontal

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Qiagen (QGEN) or Lifecore Biomedical (LFCR) more_horizontal

Lifecore Biomedical, Inc. is running a sale process. Laughing Water Capital believes upside of 150% is possible over the next three months. The Compan more_horizontal

Lifecore Biomedical, Inc. (NASDAQ:LFCR ) Q3 2023 Earnings Conference Call June 1, 2023 8:30 AM ET Company Participants Jim Hall - President John Morbe more_horizontal

Lifecore Biomedical jumped 50% yesterday after the company finally dispelled the previous going concern risk. Despite the share price jump, there are more_horizontal

Shares of Lifecore Biomedical on Monday climbed 19% to $6.40 in after-hours trading after the company said it secured a new $150 million financing agr more_horizontal